AUC passes with 0.05 and Cmax with 0.0294 [Two-Stage / GS Designs]

posted by Mikalai  – Belarus, 2019-09-18 16:56 (331 d 07:30 ago) – Posting: # 20611
Views: 3,819

Dear Helmut,

» 1. If interim power is <80%, your assumptions about the CV were not correct. Assess the study with the adjusted α 0.0294.
»    a. If you pass, stop.

What prevents us from evaluating the bioequivalence at α-level of 5% as the first step, and if we pass the bioequivalence criteria, we stop the trial. If we fail, we then evaluate the power. If power is more than 80% for the failed parameter, we stop the trial and we are done. If power is less than 80% for the failed parameter, then we go the next stage and adust α-level correspondingly to preserve overall α-level at 0,5. Of course, this should be written in the protocol and is a deviation, maybe a big one, from Potvin C method.
Regards,
Mikalai

Complete thread:

Activity
 Admin contact
21,026 posts in 4,382 threads, 1,460 registered users;
online 20 (0 registered, 20 guests [including 13 identified bots]).
Forum time: Saturday 00:26 CEST (Europe/Vienna)

It has yet to be proven
that intelligence has any survival value.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5